Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Roca

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|June 7, 2018
Identification of new allosteric sites and modulators of AChE through computational and experimental toolsCarlos Roca, Carlos Requena, Víctor Sebastián-Pérez, et al.
Annals of the Rheumatic Diseases|March 14, 2019
Machine learning identifies an immunological pattern associated with multiple juvenile idiopathic arthritis subtypesErika Van Nieuwenhove, Vasiliki Lagou, Lien Van Eyck, et al.
Scientific Reports|June 26, 2019
QSAR Classification Models for Predicting the Activity of Inhibitors of Beta-Secretase (BACE1) Associated with Alzheimer's DiseaseIgnacio Ponzoni, Víctor Sebastián-Pérez, María J Martínez, et al.
Scientific Reports|May 27, 2017
Hybridizing Feature Selection and Feature Learning Approaches in QSAR Modeling for Drug DiscoveryIgnacio Ponzoni, Víctor Sebastián-Pérez, Carlos Requena-Triguero, et al.
Bioorganic & Medicinal Chemistry|February 16, 2019
Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's diseasePeterson de Andrade, Susimaire P Mantoani, Paulo Sérgio Gonçalves Nunes, et al.
European Journal of Medicinal Chemistry|January 17, 2018
Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: Potent butyrylcholinesterase inhibitorsTalita P C Chierrito, Susimaire Pedersoli-Mantoani, Carlos Roca, et al.
European Cardiology|November 13, 2018
Secondary Prevention in Patients with Non Valvular Atrial Fibrillation and Previous Stroke. Is It Possible to Have an Appropriate INR Control?Mario Diaznuila Alcazar, Daniel Valcárcel-Paz, Marcel Santaló-Corcoy, et al.
European Journal of Medicinal Chemistry|January 28, 2019
Indazolylketones as new multitarget cannabinoid drugsPedro González-Naranjo, Natalia Pérez-Macias, Concepción Pérez, et al.
Journal of Medicinal Chemistry|July 3, 2018
Deciphering the Inhibition of the Neuronal Calcium Sensor 1 and the Guanine Exchange Factor Ric8a with a Small Phenothiazine Molecule for the Rational Generation of Therapeutic Synapse Function RegulatorsCarlos Roca, Loreto Martinez-González, Miguel Daniel-Mozo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patientsTania Crombet, Marta Osorio, Teresa Cruz, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Enzyme Inhibition and Medicinal Chemistry|June 7, 2018
Identification of new allosteric sites and modulators of AChE through computational and experimental toolsCarlos Roca, Carlos Requena, Víctor Sebastián-Pérez, et al.
Annals of the Rheumatic Diseases|March 14, 2019
Machine learning identifies an immunological pattern associated with multiple juvenile idiopathic arthritis subtypesErika Van Nieuwenhove, Vasiliki Lagou, Lien Van Eyck, et al.
Scientific Reports|June 26, 2019
QSAR Classification Models for Predicting the Activity of Inhibitors of Beta-Secretase (BACE1) Associated with Alzheimer's DiseaseIgnacio Ponzoni, Víctor Sebastián-Pérez, María J Martínez, et al.
Scientific Reports|May 27, 2017
Hybridizing Feature Selection and Feature Learning Approaches in QSAR Modeling for Drug DiscoveryIgnacio Ponzoni, Víctor Sebastián-Pérez, Carlos Requena-Triguero, et al.
Bioorganic & Medicinal Chemistry|February 16, 2019
Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's diseasePeterson de Andrade, Susimaire P Mantoani, Paulo Sérgio Gonçalves Nunes, et al.
European Journal of Medicinal Chemistry|January 17, 2018
Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: Potent butyrylcholinesterase inhibitorsTalita P C Chierrito, Susimaire Pedersoli-Mantoani, Carlos Roca, et al.
European Cardiology|November 13, 2018
Secondary Prevention in Patients with Non Valvular Atrial Fibrillation and Previous Stroke. Is It Possible to Have an Appropriate INR Control?Mario Diaznuila Alcazar, Daniel Valcárcel-Paz, Marcel Santaló-Corcoy, et al.
European Journal of Medicinal Chemistry|January 28, 2019
Indazolylketones as new multitarget cannabinoid drugsPedro González-Naranjo, Natalia Pérez-Macias, Concepción Pérez, et al.
Journal of Medicinal Chemistry|July 3, 2018
Deciphering the Inhibition of the Neuronal Calcium Sensor 1 and the Guanine Exchange Factor Ric8a with a Small Phenothiazine Molecule for the Rational Generation of Therapeutic Synapse Function RegulatorsCarlos Roca, Loreto Martinez-González, Miguel Daniel-Mozo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patientsTania Crombet, Marta Osorio, Teresa Cruz, et al.
Pageof 4